$OPBK

OP Bancorp (OPBK): Results of Operations and Financial Condition

OP Bancorp (OPBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 opbk8-kerx2026xq2xex991.htm EX-99.1 Document News Release OP Bancorp Reports Second Quarter 2026 Net Income of $8.0 Million, Diluted EPS of $0.53 compared with first quarter 2026 net income of $7.2 million, diluted EPS of $0.48, and second quarter 2025 net income of $6.

Original reporting
Published Jul 23, 2026, 8:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OPBK
Bullish
medium confidence
Mentioned
$OPBK
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OPBKBullishMed
01

Why it matters

2Q2026 results show higher net income and EPS versus both 1Q2026 and 2Q2025, supported by revenue growth and a reversal of credit-loss provision. Net interest margin fell to 3.08% due to a one-time Federal Reserve account accrual adjustment, while credit quality metrics (low net charge-offs, robust allowance coverage) remained supportive.

02

Market read

Traders can update near-term expectations for OPBK’s earnings power by separating recurring revenue/credit strength from one-time NIM and provision drivers.

03

What to watch

Watch whether the CRE nonaccrual payoff is repeatable and how loan yield and deposit costs trend after the Federal Reserve account accrual adjustment effects wash out.

Relevance 7/10Novelty 7/10Timing: after-hours following the 8-K earnings release for 2Q2026

Background

The company filed an SEC 8-K with its 2Q2026 results of operations and financial condition (Exhibit 99.1).

Company-level read

Ticker impact

$OPBKBullishMedium confidence
Context

OP Bancorp reported 2Q2026 net income of $8.0M and diluted EPS of $0.53, with a reversal of credit-loss provision tied to a CRE nonaccrual payoff.

Expected impact

Near-term bias positive as the print confirms earnings strength and low charge-offs, but NIM sensitivity to one-time accruals may cap upside.

Evidence & confidence

The filing provides specific quarterly datapoints (net income, EPS, NIM, provision reversal, charge-offs, CET1) that can re-anchor expectations for credit costs and earnings quality. However, the NIM decline is explicitly linked to one-time accrual mechanics, reducing durability confidence.

Market effects

Read-across for small bank credit quality and earnings sensitivity to CRE nonaccrual resolution and reserve/provision dynamics.

Limited, as the disclosure is company-specific to OP Bancorp and does not indicate broader regional banking stress or funding dislocation.

Low; no cross-border or macro policy action beyond the referenced Federal Reserve account accrual mechanics.

Counterpoint

The NIM decline and the provision reversal may be partly non-recurring, so the earnings quality could fade in subsequent quarters if credit normalization reverses.

Key entities

  • OP Bancorp (Open Bank)

    Reported 2Q2026 net income of $8.0M and diluted EPS of $0.53, with credit provision reversal and NIM contraction tied to Federal Reserve account accrual mechanics.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.